Literature DB >> 3557619

Specific and nonspecific mediation of protective immunity to Toxoplasma gondii.

L Reyes, J K Frenkel.   

Abstract

We studied the specificity of protection conferred by Toxoplasma gondii immune lymphocytes and their supernatants on infected hamster kidney cells, using Besnoitia jellisoni immune lymphocytes as a nonspecific control. The intracellular growth of the organisms was measured by [3H]uracil incorporation, and inhibition of multiplication was used as a measurement of immunity. Although the immune lymphocytes restricted principally the multiplication of homologous organisms, partial protection, expressed against the heterologous organism, was found. This was true for either parasite with intact lymphocytes or their supernatants. Exposure of immune lymphocytes to antigen for 18 to 24 h and treatment of kidney cells with supernatant fluids for 18 to 24 h were required for maximal protection. The specific protective mediator in supernatants of immune lymphocytes was characterized by dialysis as having a molecular weight between 3,000 and 12,000 and was found in the 3,000 to 5,000 peak after Sephadex G-50 chromatography. Nonspecific protective activity was greater than 12,000 by dialysis; it chromatographed in the excluded peak, measuring over 43,000, and was destroyed by exposure to pH 2. In vitro production of lymphokines from toxoplasma immune lymphocytes was first detected 7 to 10 days after vaccination of hamsters. At about the same time, hamsters began to resist challenge infection with the pathogenic RH strain of T. gondii and were able to prevent its multiplication in lungs, liver, spleen, and the subcutaneous infection site. The expression of tissue immunity and the production of toxoplasma-immune lymphokines appear to be time-related events.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3557619      PMCID: PMC260429          DOI: 10.1128/iai.55.4.856-863.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  J S Youngner; S B Salvin
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

Review 2.  The biology of monoclonal lymphokines secreted by T cell lines and hybridomas.

Authors:  A Altman; D H Katz
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

3.  Effect of murine interferon gamma on murine toxoplasmosis.

Authors:  R E McCabe; B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

4.  Specific mediation of cellular immunity to Toxoplasma gondii in somatic cells of mice.

Authors:  M Chinchilla; J K Frenkel
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

5.  Toxoplasma gondii: microassay to differentiate toxoplasma inhibiting factor and interleukin 2.

Authors:  P E Baker; A Hagemo; K Knoblock; J P Dubey
Journal:  Exp Parasitol       Date:  1983-06       Impact factor: 2.011

6.  Toxoplasmosis in immunoglobulin M-suppressed mice.

Authors:  J K Frenkel; D W Taylor
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Macrophage-activating factors from different T cell clones induce distinct macrophage functions.

Authors:  D Gemsa; K M Debatin; W Kramer; C Kubelka; W Deimann; U Kees; P H Krammer
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

8.  Acute toxoplasmosis in hamsters and mice: measurement of pathogenicity by fever and weight loss.

Authors:  M R Elwell; J K Frenkel
Journal:  Am J Vet Res       Date:  1984-12       Impact factor: 1.156

9.  Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products.

Authors:  J S Borges; W D Johnson
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  3 in total

1.  Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Authors:  Y Zhang; E Y Denkers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Human T-cell clones against Toxoplasma gondii: production of interferon-gamma, interleukin-2, and strain cross-reactivity.

Authors:  R Saavedra; P Hérion
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

Review 3.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.